About the Department of Molecular Microbiology and Immunology
Consistently tackling hard questions in the quest of curing or treating ailments
The ongoing vision of the Department of Molecular Microbiology and Immunology (MMI) is to build up a world-class research program to address some of the biggest problems plaguing public health and human health. Department faculty members have made and will continue to make strides in the areas of tumor virology, microbial infection, AIDS, autoimmune diseases and cancer.
The department is continuously seeking ways to collaborate, to use modern technologies and techniques, to develop top-of-the-line infrastructure and to recruit the best researchers. In addition, MMI has outstanding core facilities including flow cytometry and sorting, confocal microscopy, mass spectrometry, metabolomics and Biosafety Level 3. The department’s long-term vision is to build up a robust research program that can make high impact contributions to scientific knowledge. The department also aims to adapt quickly in response to evolving research topics of pathogens and immune diseases and ultimately contribute to the development of therapies and vaccines against pathogens and immune diseases.
Facts & Figures
- 25 faculty
- 22 laboratories
- core facilities in flow cytometry, imaging core, mass spectrometry, metabolomics, and BSL3
- courses and training at master’s, PhD, and postdoctoral levels
- more than $18 million total cost in research grants
- recent publications in top journals including Nature, Nature Biotechnology, Nature Communication, Immunity, Proceedings of the National Academy of Sciences (PNAS), Molecular Cell, etc.